Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide.


Updates from The Motley Fool

Latest updates on Amyris from Fool.com.  The Fool has written over 100 articles on Amyris.


Stock Performance

View Interactive AMRS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Amyris.
Current Price: $3.81
Prev Close: $3.93
Open: $3.94
Bid: $3.70
Ask: $4.10
Day's Range: $3.80 - $4.08
52wk Range: $2.64 - $9.28
Volume: 1,971,786
Avg Vol 4,352,071
Market Cap: $189M
P/E (ttm): -1.62
EPS (ttm): -$2.43
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Amyris.
CAPS Rating 1 out of 5
 
83 Outperform
19 Underperform
CAPS All Stars
 
7 Outperform
9 Underperform

How do you think Amyris will perform against the market?



You pick for Amyris is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John Melo, CEO

77% Approve

Based on 38 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Amyris.

Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers